InvestorsHub Logo
Followers 3156
Posts 960683
Boards Moderated 203
Alias Born 09/04/2000

Re: None

Tuesday, 11/17/2015 6:18:23 PM

Tuesday, November 17, 2015 6:18:23 PM

Post# of 3504
PRODUCT PORTFOLIO

http://www.cbiolabs.com/

Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines.

View Our Product Portfolio

Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and as an immunotherapy for oncology and other indications.

Entolimod (CBLB502) Biodefense
Entolimod (CBLB502) Oncology